PA
IONS icon

Profund Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Profund Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Sell
26,287
-386
-1% -$30.5K 0.07% 211
2025
Q4 		$2.11M Buy
26,673
+741
+3% +$55.8K 0.06% 205
2025
Q3 		$1.7M Sell
25,932
-2,927
-10% -$143K 0.06% 223
2025
Q2 		$1.14M Sell
28,859
-6,028
-17% -$197K 0.04% 274
2025
Q1 		$1.05M Sell
34,887
-8,672
-20% -$284K 0.05% 287
2024
Q4 		$1.52M Buy
43,559
+5,963
+16% +$223K 0.06% 224
2024
Q3 		$1.51M Buy
37,596
+7,613
+25% +$354K 0.06% 245
2024
Q2 		$1.43M Sell
29,983
-1,587
-5% -$65.1K 0.05% 239
2024
Q1 		$1.37M Buy
31,570
+2,497
+9% +$119K 0.05% 271
2023
Q4 		$1.47M Sell
29,073
-6,397
-18% -$306K 0.06% 250
2023
Q3 		$1.61M Sell
35,470
-814
-2% -$33.6K 0.09% 175
2023
Q2 		$1.49M Sell
36,284
-125
-0.3% -$4.8K 0.08% 207
2023
Q1 		$1.3M Buy
36,409
+20,564
+130% +$772K 0.08% 226
2022
Q4 		$598K Buy
15,845
+368
+2% +$15.5K 0.04% 378
2022
Q3 		$685K Sell
15,477
-726
-4% -$30.6K 0.05% 309
2022
Q2 		$600K Sell
16,203
-1,389
-8% -$52.4K 0.04% 380
2022
Q1 		$652K Sell
17,592
-1,825
-9% -$59.7K 0.03% 442
2021
Q4 		$591K Sell
19,417
-3,474
-15% -$109K 0.02% 518
2021
Q3 		$768K Sell
22,891
-1,167
-5% -$44K 0.03% 448
2021
Q2 		$959K Sell
24,058
-739
-3% -$28.9K 0.03% 364
2021
Q1 		$1.11M Sell
24,797
-3,692
-13% -$206K 0.04% 284
2020
Q4 		$1.61M Buy
28,489
+2,520
+10% +$126K 0.07% 231
2020
Q3 		$1.23M Sell
25,969
-2,127
-8% -$118K 0.06% 243
2020
Q2 		$1.66M Buy
28,096
+4,045
+17% +$225K 0.09% 191
2020
Q1 		$1.14M Sell
24,051
-8,773
-27% -$489K 0.09% 215
2019
Q4 		$1.98M Buy
32,824
+3,399
+12% +$203K 0.09% 214
2019
Q3 		$1.76M Sell
29,425
-5,142
-15% -$335K 0.09% 213
2019
Q2 		$2.22M Sell
34,567
-3,762
-10% -$266K 0.11% 182
2019
Q1 		$3.11M Buy
38,329
+544
+1% +$35.1K 0.15% 127
2018
Q4 		$2.04M Sell
37,785
-9,137
-19% -$466K 0.13% 145
2018
Q3 		$2.42M Buy
46,922
+7,934
+20% +$373K 0.09% 188
2018
Q2 		$1.63M Sell
38,988
-2,369
-6% -$105K 0.06% 246
2018
Q1 		$1.82M Sell
41,357
-4,400
-10% -$224K 0.07% 235
2017
Q4 		$2.3M Sell
45,757
-5,723
-11% -$314K 0.09% 198
2017
Q3 		$2.61M Buy
51,480
+4,206
+9% +$220K 0.11% 164
2017
Q2 		$2.4M Sell
47,274
-2,156
-4% -$100K 0.11% 157
2017
Q1 		$1.99M Sell
49,430
-4,101
-8% -$184K 0.09% 195
2016
Q4 		$2.56M Sell
53,531
-8,401
-14% -$332K 0.12% 132
2016
Q3 		$2.27M Sell
61,932
-3,193
-5% -$99.9K 0.11% 160
2016
Q2 		$1.52M Sell
65,125
-2,619
-4% -$84.5K 0.07% 233
2016
Q1 		$2.74M Sell
67,744
-16,590
-20% -$674K 0.14% 106
2015
Q4 		$5.22M Sell
84,334
-627
-0.7% -$33.8K 0.25% 63
2015
Q3 		$3.43M Sell
84,961
-4,482
-5% -$232K 0.2% 72
2015
Q2 		$5.15M Sell
89,443
-3,866
-4% -$246K 0.21% 65
2015
Q1 		$5.94M Buy
93,309
+5,915
+7% +$401K 0.23% 63
2014
Q4 		$5.4M Buy
87,394
+8,866
+11% +$437K 0.22% 73
2014
Q3 		$3.05M Buy
78,528
+805
+1% +$28.5K 0.14% 114
2014
Q2 		$2.68M Sell
77,723
-17,870
-19% -$563K 0.12% 142
2014
Q1 		$4.13M Buy
95,593
+19,855
+26% +$962K 0.19% 77
2013
Q4 		$3.02M Buy
75,738
+15,378
+25% +$548K 0.14% 99
2013
Q3 		$2.27M Buy
60,360
+3,923
+7% +$117K 0.12% 121
2013
Q2 		$1.52M Buy
+56,437
New +$1.2M 0.11% 153

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Profund Advisors's IONS Position: Q1 2026 in Review

Profund Advisors reduced its Ionis Pharmaceuticals (IONS) stake by 1.4% in Q1 2026, selling an estimated $30.5K and leaving 26,287 shares worth $1.97M. The position accounts for 0.07% of the portfolio, ranked #211.

Profund Advisors first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.94M in Q1 2015. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Profund Advisors held 26,287 shares of Ionis Pharmaceuticals worth $1.97M as of Q1 2026.
  • Profund Advisors sold 386 Ionis Pharmaceuticals shares in Q1 2026, an estimated $30.5K.
  • Ionis Pharmaceuticals made up 0.07% of Profund Advisors's portfolio in Q1 2026, its #211 holding.
  • Profund Advisors first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Profund Advisors's Ionis Pharmaceuticals position peaked at $5.94M in Q1 2015.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.